Huawei Unveils $430 Million Investment to Boost Digital Africa
SHANGHAI— The eighth edition of Huawei Connect has opened its doors in Shanghai from September 20 to 22, marking its first event since the global health crisis. This year’s spotlight is on artificial intelligence (AI), reflecting Huawei’s key focus for the African continent. During the Huawei Northern Africa Night event on September 20, Terry HE, President […]
Chery, leading the future in technology, debuted at the Shanghai Auto Show
Dubai, United Arab Emirates — On April 18th, the 20th Shanghai International Automobile Industry Exhibition opened grandly at the Shanghai National Convention and Exhibition Center. At the world’s largest and most influential international A-class auto show, Chery Motors released its third-generation PHEV technology, showcasing its latest development path in the face of opportunities in the […]
Leapmotor unveils its entire new product line at the Shanghai International Auto Show
SHANGHAI — On April 18th, the 20th Shanghai International Auto Show officially kicked off, and Leapmotor (Zhejiang Leapmotor Technology Co Ltd, HKG: 9863) brought its entire new product line to the event, including the C11 extended range model, the 2023 C01, C11, and T03. Leapmotor Chairman Zhu Jiangming, along with other executives, transformed into “super […]
Accutar Biotechnology Announces First Patient Dosed in China with AC0176 in Phase 1 Study in Prostate Cancer
CRANBURY, N.J. & SHANGHAI — Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces the dosing of the first patient in China in a Phase 1 study of AC0176, an orally bioavailable chimeric degrader molecule designed to target Androgen Receptor (AR) protein with high potency and selectivity. “The […]
Accutar Biotechnology Announces First Patient Dosed in China with AC0682 in Phase 1 Study in ER-Positive Breast Cancer
CRANBURY, N.J. & SHANGHAI — Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces the dosing of the first patient in China in a Phase 1 study of AC0682, an orally bioavailable chimeric degrader molecule designed to target ERα protein with high potency and selectivity. “The initiation of […]
CHINT’s Path to CSR: Four Years of Dedication in Egypt
SHANGHAI – CHINT values nothing higher than its responsibility to the community. CHINT’s subsidiary in Egypt established roots in the local community as soon as it was set up in 2019, sparing no effort to support the Egyptian people and forming strong links across the country through charitable endeavors. Recently, the Egyptian subsidiary and the […]